Features | Partner Sites | Information | LinkXpress
Sign In
GLOBETECH PUBLISHING LLC
GLOBETECH MEDIA
GLOBETECH PUBLISHING LLC

Business

Program Designed to Provide High-Performance Computing Cluster Systems for Bioinformatics Research

Dedicated Computing, a global technology company, reported that it will be participating in the Intel Cluster Ready program to deliver integrated high-performance computing cluster solutions to the life sciences market.    More...
25 Jan 2015

Biotech Acquisition Designed to Accelerate the Development and Marketing of Immunosequencing Applications

Adaptive Biotechnologies, a developer of next-generation sequencing (NGS) to profile T-cell and B-cell receptors, has acquired of Sequenta, which is expected to expedite and expand the use of innovative immunosequencing technology for researchers and clinicians to diagnose, treat, and monitor patients with cancer, autoimmune disorders, and infectious diseases.  More...
19 Jan 2015

Strategic Alliance Will Promote Genetics Discovery Research

A major representative of the biotech industry will be collaborating with one of the United States' premiere research institutions in a 30 million USD strategic alliance to conduct genetics discovery research on the underlying causes of disease and to identify new treatment approaches.  More...
18 Jan 2015

Partnership to Launch Wireless Brain Research System

Neuroscience research is now going wireless with the use of a new neural activity monitoring system.  More...
07 Jan 2015

United Kingdom to Build a New Cell and Gene Therapy Manufacturing Center

The United Kingdom Cell Therapy Catapult plans to build the new GBP 55-million Cell Therapy manufacturing center in the Stevenage Bioscience Catalyst campus.   More...
04 Jan 2015

Merger Expected to Accelerate Development of Personalized Medicine Solutions

Acquisition of an American company specializing in data management and analysis by a worldwide leader in genomics research and diagnostics development is expected to decrease the complexity, time, and cost of genomic analysis and accelerate development of the science of personalized medicine.  More...
28 Dec 2014

R&D Partnership Initiated to Reduce Development Time for New Drugs

nanoPET Pharma signed an open-ended framework contract with the international pharmaceutical company Boehringer Ingelheim. By developing customized contrast agents for research in both basic and preclinical studies, nanoPET Pharma will contribute to the enhancement of Boehringer Ingelheim’s imaging diagnostics. The first joint projects have already begun and many more are being planned.    More...
09 Dec 2014


BioResearch Industry News channel updates the reader on mergers and takeovers, on cooperative agreements and on trends in the biotech industry worldwide.
 
Copyright © 2000-2015 Globetech Media. All rights reserved.